Seeking Digital Technologies Innovators to Apply for the First Johnson & Johnson Innovation QuickFire Challenge for Medical Devices in China
The rapidly expanding China health market provides an opportunity for innovators to help shape the future of the country’s healthcare. Improving health outcomes is now a national priority, with the Healthy China 2030 mandate aiming to promote public health, disease prevention, and a significant expansion of China’s health industry within the next decade. China was also named by the 2019 Future of Health Index as a “forerunner” in the adoption of new healthcare technologies.
Almost 30 years ago, Johnson & Johnson Medical China began operating in China with a focus on building the market by investing in professional education for clinicians. Today, we have shifted our focus from bringing the latest global innovations to the region to cultivating the cutting-edge technologies being developed here. We have shifted to a model that aims to drive the development of new science and technologies, including through the direct support of entrepreneurs and innovators.
In my role as Head of Innovation with Johnson & Johnson Medical China, I am inspired and encouraged by the many possibilities in front of us. By seeking out and supporting new ideas, we have the potential to solve for unmet patient needs and advance the standard of care in the China market and beyond.
For over two years, my team has worked diligently to develop the structural support needed to experiment with innovative products, having explored additional application areas for new technologies. Our next step is to look outside our immediate organization and form long-term partnerships with health innovators, collaborating to help us learn about the latest in cutting-edge science while lending our industry expertise to take novel innovations to market.
Emerging technologies like artificial intelligence (AI), 3D-printing, and IoT may be the key to unlocking the future for China healthcare. Advancing these digital technologies can allow for earlier access and more precise diagnostics and treatments for key areas like atrial fibrillation (AFIB), neurovascular treatments, orthopedics, and general surgery.
However, we have found that groundbreaking technology alone isn’t enough. Understanding how that technology can work within health care and having a clear vision for specific use-cases could be key to delivering solutions to the patient.
To that end, I am proud to be spearheading the first Johnson & Johnson Innovation QuickFire Challenge for medical devices in China, an initiative we hope will be an opening of doors for China technologies to the rest of the world. The Digital Technologies of Tomorrow QuickFire Challenge invites visionaries to submit their novel, medical device ideas with the potential to transform patient care in AFIB, neurovascular treatments, orthopedic and general surgery.
Innovators that can demonstrate a strong, potential use-case and tangible impact for their technology are encouraged to apply. The innovator or entrepreneur(s) with the best idea will receive grant funding up to a total of $100,000, residency at JLABS @ Shanghai including a workstation and access to the JLABS ecosystem, and mentorship from experts from the Johnson & Johnson Family of Companies.
The deadline to submit applications is quickly approaching on March 19, 2021.
For more information or to submit your idea, please visit https://jlabs.jnjinnovation.com/quickfire-challenges/digital-technologies-tomorrow-quickfire-challenge.